1. |
Steinmuller T, Seehofer D, Rayes N, et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease [J]. Hepatology, 2002; 35(6)∶1528.
|
2. |
Yao FY, Terrault NA, Freise C, et al. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort [J]. Hepatology, 2001; 34(2)∶411.
|
3. |
Perrillo RP, Wright T, Rakela J, et al. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B [J]. Hepatology, 2001; 33(2)∶424.
|
4. |
Villeneuve JP, Condreay LD, Willems B, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B [J]. Hepatology, 2000; 31(1)∶207.
|
5. |
Lo CM, Cheung ST, Lai CL, et al. Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis [J]. Ann Surg, 2001; 233(2)∶276.
|
6. |
Perillo RP. Potential importance of the sexual transmission of non-A, non-B hepatitis [J]. Hepatology, 1991; 13(4)∶805.
|
7. |
Fontana RJ, Hann HW, Perrillo RP, et al. Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy [J]. Gastroenterology, 2002; 123(3)∶719.
|
8. |
Peters MG, Hann Hw H, Martin P, et al. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B [J]. Gastroenterology, 2004; 126(1)∶91.
|
9. |
Schiff ER, Lai CL, Hadziyannis S, et al. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients [J]. Hepatology, 2003; 38(6)∶1419.
|
10. |
Villeneuve JP, Durantel D, Durantel S, et al. Selection of a hepatitis B virus strain resistant to adevir in a liver transplantation patient [J]. J Hepalo, 2003; 39(6)∶1085.
|
11. |
Yang H, Westland CE, Delaney WE 4th, et al. Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks [J]. Hepatology, 2002; 36(2)∶464〖HJ*2〗12 Grellier L, Mutimer D, Ahmed M, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis [J]. Lancet, 1996; 348(9036)∶1212.
|
12. |
严茂林, 严律南, 李波, 等. 拉米夫定对肝移植术后乙肝病毒再感染的预防作用 [J]. 中国普外基础与临床杂志, 2006; 13(2)∶205.
|
13. |
Mutimer D, Pillay D, Shields P, et al. Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient [J]. Gut, 2000; 46(1)∶107.
|
14. |
Wai CT, Prabhakaran K, Wee A, et al. Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant [J]. Transplant Proc, 2004; 36(8)∶2313.
|
15. |
Palumbo E. Recent advances in the treatment of the hepatitis HBV-related. Effectiveness and tolerability of adefovir dipivoxil [J]. Recenti Prog Med, 2007; 98(4)∶237.
|
16. |
Barcena R, Del Campo S, Moraleda G, et al. Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus [J]. Transplant Proc, 2005; 37(9)∶3960.
|
17. |
Yoshida H, Kato T, Levi DM, et al. Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection [J]. Clin Transplant, 2007; 21(2)∶166.
|
18. |
Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen [J]. N Engl J Med, 1993; 329(25)∶1842.
|
19. |
Roche B, Feray C, Gigou M, et al. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis [J]. Hepatology, 2003; 38(1)∶86.
|
20. |
Devlin J, Smith HM, O’Grady JG, et al. Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients [J]. J Hepatol, 1994; 21(2)∶204.
|
21. |
Terrault NA, Zhou S, Combs C, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin [J]. Hepatology, 1996; 24(6)∶1327.
|
22. |
Terrault NA, Zhou S, McCory RW, et al. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin [J]. Hepatology, 1998; 28(2)∶555.
|
23. |
Shouval D, Samuel D. Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review [J]. Hepatology, 2000; 32(6)∶1189.
|
24. |
Mentha G, Giostra E, Negro F, et al. High-titered anti-HBs fresh frozen plasma for immunoprophylaxis against hepatitis B virus recurrence after liver transplantation [J]. Transplant Proc, 1997; 29(5)∶2369.
|
25. |
Terrault NA, Vyas G. Hepatitis B immune globulin preparations and use in liver transplantation [J]. Clin Liver Dis, 2003; 7(3)∶537.
|
26. |
Angus PW, McCaughan GW, Gane EJ, et al. Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B [J]. Liver Transpl, 2000; 6(4)∶429.
|
27. |
Neff GW, Kemmer N, Kaiser TE, et al. Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin [J]. Dig Dis Sci, 2007; 52(10)∶2497.
|
28. |
Bock CT, Tillmann HL, Torresi J, et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation [J]. Gastroenterology, 2002; 122(2)∶264.
|
29. |
Dodson SF, de Vera ME, Bonham CA, et al. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation [J]. Liver Transpl, 2000; 6(4)∶434.
|
30. |
Naoumov NV, Lopes AR, Burra P, et al. Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation [J]. J Hepatol, 2001; 34(6)∶888.
|
31. |
Neff GW, O’brien CB, Nery J, et al. Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade [J]. Liver Transpl, 2004; 10(11)∶1372.
|